(1 - 10 from 11
)
Helix Biopharma Corp. Announces Leadership Transition
www.finanznachrichten.de
"Helix is entering an exciting time for the company as it continues to develop the DOS47 oncology platform technology," said Yvon Bastien, ...
Helix BioPharma Names Yvon Bastien New Chair Of The Board
www.rttnews.com
Canada-based Helix BioPharma Corp (HBP.TO) said Monday it has named Yvon Bastien as the new chair of the board effective July 17. Bastien has served as an independent ...
Helix Biopharma Corp. Announces Leadership Transition
www.globenewswire.com
· ... the board of directors' intention to appoint Yvon Bastien to serve as interim CEO if a new CEO is not appointed prior to November 1, ...
sorted by relevance / date